Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.946 USD | +0.71% | +65.49% | +3.10% |
Business Summary
Number of employees: 135
Managers
Managers | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 25/15/25 |
Bryan Giraudo
DFI | Director of Finance/CFO | 49 | 07/18/07 |
Chief Tech/Sci/R&D Officer | - | 03/23/03 | |
Richard Aranda
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/18/01 |
Christian Waage
ADM | Chief Administrative Officer | 57 | 01/17/01 |
Bob Smith
PRN | Corporate Officer/Principal | 55 | 05/12 |
Jeff Boerneke
LAW | General Counsel | - | 01/21/01 |
Deanna Weber
HRO | Human Resources Officer | - | 01/18/01 |
Caryn Peterson
LAW | General Counsel | 65 | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 25/15/25 |
Thomas Daniel
BRD | Director/Board Member | 70 | 01/18/01 |
Skye Drynan
BRD | Director/Board Member | 48 | 11/03 |
John Quisel
BRD | Director/Board Member | 52 | 28/11 |
Russell Cox
BRD | Director/Board Member | 60 | 19/18/19 |
Sandra Milligan
BRD | Director/Board Member | 60 | 10/21/10 |
Steven Nathan
BRD | Director/Board Member | 65 | 11/03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 226,218,652 | 219,535,762 ( 97.05 %) | 0 | 97.05 % |
Company contact information
Gossamer Bio, Inc.
3013 Science Park Road Suite 200
92121, San Diego
+858 684 1300
http://www.gossamerbio.comGroup companies
Name | Category and Sector |
---|---|
Gossamer Bio Services, Inc.
Gossamer Bio Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Gossamer Bio, Inc., Gossamer Bio Services, Inc. operates as an American biopharmaceutical company which discovers, develops and commercializes immunology-based therapeutics. The company is located in the US. |
Pharmaceuticals: Major
|
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.10% | 212M | |
+22.51% | 46.93B | |
+37.63% | 39.08B | |
-8.03% | 38.48B | |
+29.16% | 31.01B | |
-13.75% | 26.14B | |
+10.74% | 25.88B | |
+37.72% | 12.53B | |
-6.96% | 11.36B | |
-12.41% | 10.65B |
- Stock Market
- Equities
- GOSS Stock
- Company Gossamer Bio, Inc.